Nokes Rachael 4
4 · scPharmaceuticals Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
Nokes Rachael
CFO and Treasurer
Transactions
- Tax Payment
Common Stock
2020-02-25$10.09/sh−1,981$19,988→ 11,869 total - Tax Payment
Common Stock
2021-02-25$7.27/sh−1,976$14,366→ 9,893 total - Award
Stock Option (right to buy)
2023-01-19+17,550→ 17,550 totalExercise: $6.14Exp: 2033-01-19→ Common Stock (17,550 underlying) - Award
Common Stock
2023-01-19$6.14/sh+11,700$71,838→ 21,593 total
Footnotes (3)
- [F1]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.
- [F2]Consists of a restricted stock unit ("RSU") award made pursuant to the ScPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2023, such that the RSUs will be fully vested on January 1, 2027.
- [F3]The option shares vest over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2027.